LifeVantage Pledges Donation to Linus Pauling Institute
08 October 2021 - 12:00AM
LifeVantage Corporation (Nasdaq:LFVN) today announced that it has
pledged a five-year donation commitment to the Linus Pauling
Institute (“LPI” or “the Institute”) at Oregon State University.
The pledge will be added to the Linus Pauling Institute Research
Innovation Fund, which is used to support the Institute’s mission
of promoting optimal health through cutting-edge nutrition research
and trusted public outreach.
In conjunction with the donation, Dr. Brian Dixon, LifeVantage
Senior Vice President of Research & Development, will join the
Director’s Circle at LPI, an advisory board that provides strategic
advice to the Director of the Institute and its Director of
Development.
“The Linus Pauling Institute is a world-class leader in health
and wellness research,” commented Dr. Dixon. “Their innovative
programs provide critical insights on the impact of dietary factors
such as micronutrients and phytochemicals in optimizing health. The
Institute’s goal of equipping every person with the knowledge and
tools to optimize their health is perfectly aligned with our
mission at LifeVantage.”
Dr. Dixon continued, “Our donation to the LPI offers several key
benefits for LifeVantage including the potential to partner with
their Micronutrient Information Center and leverage the power of
third-party research. We’ll also be able to actively engage with
researchers at the Institute and be uniquely positioned around the
latest innovations in the areas of nutrients, phytochemicals, and
human health.”
Professor Emily Ho, Endowed Chair and Director of the Linus
Pauling Institute, commented, “We are grateful for the support of
LifeVantage and recognized experts like Dr. Dixon. Partnering with
industry leaders is core to our strategy, helping drive strong
outcomes related to our mission of helping everyone live healthier,
longer.”
About the Linus Pauling Institute
The Linus Pauling Institute's mission is to promote optimal
health through cutting-edge nutrition research and trusted public
outreach. Dr. Linus Carl Pauling concluded that vitamins and other
essential micronutrients play a significant role in enhancing
health. Nearly 50 years ago, Dr. Pauling co-founded the Institute
to carry out research in this field that he believed would be of
enormous importance to public health. After Pauling's death, the
Linus Pauling Institute was re-established on the campus of Oregon
State University in Corvallis, Oregon. For the past 25 years, the
Institute has thrived as one of the University’s Research Centers
and Institutes. Supported by gifts from individuals, private
corporations, and foundations, it also has support from research
grants (from private and federal agencies such as the National
Institutes of Health) and continuing support from
OSU.
About LifeVantage Corporation
LifeVantage Corporation (Nasdaq: LFVN) is a pioneer in
Nutrigenomics, the study of how nutrition and naturally occurring
compounds affect human genes to support good health. The Company
engages in the identification, research, development, formulation
and sale of advanced nutrigenomic activators, dietary supplements,
nootropics, pre- and pro-biotics, weight management, skin and hair
care, bath & body, and targeted relief products. The Company’s
line of scientifically-validated dietary supplements includes its
flagship Protandim® family of products, LifeVantage® Omega+,
ProBio, and Daily Wellness dietary supplements, TrueScience® is the
Company's line of skin, hair, bath & body, and targeted relief
products. The Company also markets and sells Petandim®, its
companion pet supplement formulated to combat oxidative stress in
dogs, Axio® its nootropic energy drink mixes, and PhysIQ™, its
smart weight management system. LifeVantage was founded in 2003 and
is headquartered in Lehi, Utah. For more information, visit
www.lifevantage.com.
Investor Relations Contact:
Reed Anderson, ICR(646) 277-1260reed.anderson@icrinc.com
Lifevantage (NASDAQ:LFVN)
Historical Stock Chart
From Apr 2024 to May 2024
Lifevantage (NASDAQ:LFVN)
Historical Stock Chart
From May 2023 to May 2024